Tonix Pharmaceuticals Holding Corp (TNXP)

[Amatuer17]

Interesting stock

Indication - PTSD - military
Potential revenue - $600 million
Current treatments - not core, unmet need

Market cap - $34 million
Cash on hand. - $29 million
Additional funding - 2.1 million shares from LPC at lowest SP formula

P2a - very successful - BTD designation
P3 - SPA approved by fda

Big milestone - unblinded Interim analysis in H1-2018 after 50% enrollment - with possibility of halting the trial due to efficacy

If IA is not as effective, final topline in late H2-2018

Risks - same drug was tried till P3 for fibromyalgia and failed to statistical significant results

There was another drug that also failed

SP at one time was $80 - it dropped and co did r/s 20:1 and listed on Nasdaq - did multiple secondary offerings to raise money but all that is in the past - those who invested few years back got burned - now the cash is clean and mc is microcap - IF P3 gives same results as P2, this is a multibagger